نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml excipient: mannitol sodium citrate dihydrate water for injection - · treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density. · prevention of postmenopausal osteoporosis.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

apotex nz ltd - zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid anhydrous 0.05 mg/ml;   - solution for injection - 5 mg/100ml - active: zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid anhydrous 0.05 mg/ml   excipient: mannitol sodium citrate water for injection - treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - zoledronic acid monohydrate 0.0533 mg/ml equivalent to to zoledronic acid 0.05 mg/ml - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 0.0533 mg/ml equivalent to to zoledronic acid 0.05 mg/ml excipient: mannitol sodium citrate dihydrate water for injection - · treatment of osteoporosis in men.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

carsl consulting - zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 0.0533 mg/ml equivalent to zoledronic acid 0.05 mg/ml excipient: mannitol sodium citrate dihydrate water for injection - treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density.

مالطا - الإنجليزية - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - zoledronic acid, monohydrate - solution for infusion - zoledronic acid monohydrate 5 mg - drugs for treatment of bone diseases

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - zoledronic acid monohydrate - solution for infusion - 50microgram/1ml

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

cipla (eu) limited - zoledronic acid monohydrate - solution for infusion - 5mg/100 millilitre - biphosphonates

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - zoledronic acid monohydrate - solution for infusion - 50microgram/1ml

مالطا - الإنجليزية - Medicines Authority

1 a pharma gmbh - zoledronic acid monohydrate 5 mg - solution for infusion

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - zoledronic acid - infusion, solution - 5mg - zoledronic acid 5mg